Delivery Order SPE2DB22D1103-SPE2DB24FTRX8

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,399.62 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a performance period through March 14, 2024. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
The U.S. Defense Logistics Agency (DLA) awarded a $2,203.97 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565698000 - Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities in support of military...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $9,282.40 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract, with a performance period through August 7, 2024, is for the supply of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with DLA Troop Support Medical for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a $3,877.89 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,454,933 units of Lidocaine 5% Patch 30s, with a period of performance ending on August 15, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is in place through December 2025....
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,459.20 firm fixed price delivery order to provide 4,563,744,113 units of Lidocaine 5% Patch 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $1,067.50 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4564490699 - Lidocaine 5% Patch 30s. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $2,608.26 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Lidocaine 5% patches. The order was placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC is the primary vehicle for AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $50,394.18 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of Lidocaine 5% Patch 30s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
The Defense Logistics Agency (DLA) awarded a $14,121.12 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,057,471 units of Lidocaine 5% patch. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTRX8
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $22,166.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4565922795 - Lidocaine 5% Patch 30s. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. There is no set-aside designation for this specific delivery order, which has an ultimate completion date of September 25, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to serve as a key medical commodity supplier to various federal agencies and healthcare providers, including the military.

Generated 12/24/24, 9:28 AM